Many retinal biologics have been approved by the Food and Drug Administration (FDA), the European Medicine Agency (EMA) and the China Food and Drug Administration (CFDA) for the treatment of retinal diseases. Advancements in technologies and new mechanism of action for different biologics to treat retinal diseases are anticipated to boost the retinal biologics market. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Retinal Biologics market in 2020. COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future. This report also analyses the impact of Coronavirus COVID-19 on the Retinal Biologics industry. Based on our recent survey, we have several different scenarios about the Retinal Biologics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Retinal Biologics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinal Biologics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinal Biologics market in terms of revenue. Players, stakeholders, and other participants in the global Retinal Biologics market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026. Regional and Country-level Analysis The report offers an exhaustive geographical analysis of the global Retinal Biologics market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026. Competition Analysis In the competitive analysis section of the report, leading as well as prominent players of the global Retinal Biologics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinal Biologics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinal Biologics market. The following players are covered in this report: Spark Therapeutics, Inc F. Hoffmann-La Roche Ltd Regeneron Pharmaceuticals, Inc AbbVie Inc Johnson & Johnson Services, Inc Amgen Inc ... Retinal Biologics Breakdown Data by Type Macular Degeneration Diabetic Retinopathy Diabetic Macular Edema Uveitis Others Retinal Biologics Breakdown Data by Application Hospitals Clinics Others
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Retinal Biologics Revenue 1.4 Market Analysis by Type 1.4.1 Global Retinal Biologics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Macular Degeneration 1.4.3 Diabetic Retinopathy 1.4.4 Diabetic Macular Edema 1.4.5 Uveitis 1.4.6 Others 1.5 Market by Application 1.5.1 Global Retinal Biologics Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Coronavirus Disease 2019 (Covid-19): Retinal Biologics Industry Impact 1.6.1 How the Covid-19 is Affecting the Retinal Biologics Industry 1.6.1.1 Retinal Biologics Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19?s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Retinal Biologics Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Retinal Biologics Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Retinal Biologics Market Perspective (2015-2026) 2.2 Retinal Biologics Growth Trends by Regions 2.2.1 Retinal Biologics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Retinal Biologics Historic Market Share by Regions (2015-2020) 2.2.3 Retinal Biologics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter?s Five Forces Analysis 2.3.5 Retinal Biologics Market Growth Strategy 2.3.6 Primary Interviews with Key Retinal Biologics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Retinal Biologics Players by Market Size 3.1.1 Global Top Retinal Biologics Players by Revenue (2015-2020) 3.1.2 Global Retinal Biologics Revenue Market Share by Players (2015-2020) 3.1.3 Global Retinal Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Retinal Biologics Market Concentration Ratio 3.2.1 Global Retinal Biologics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Retinal Biologics Revenue in 2019 3.3 Retinal Biologics Key Players Head office and Area Served 3.4 Key Players Retinal Biologics Product Solution and Service 3.5 Date of Enter into Retinal Biologics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Retinal Biologics Historic Market Size by Type (2015-2020) 4.2 Global Retinal Biologics Forecasted Market Size by Type (2021-2026) 5 Retinal Biologics Breakdown Data by Application (2015-2026) 5.1 Global Retinal Biologics Market Size by Application (2015-2020) 5.2 Global Retinal Biologics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Retinal Biologics Market Size (2015-2020) 6.2 Retinal Biologics Key Players in North America (2019-2020) 6.3 North America Retinal Biologics Market Size by Type (2015-2020) 6.4 North America Retinal Biologics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Retinal Biologics Market Size (2015-2020) 7.2 Retinal Biologics Key Players in Europe (2019-2020) 7.3 Europe Retinal Biologics Market Size by Type (2015-2020) 7.4 Europe Retinal Biologics Market Size by Application (2015-2020) 8 China 8.1 China Retinal Biologics Market Size (2015-2020) 8.2 Retinal Biologics Key Players in China (2019-2020) 8.3 China Retinal Biologics Market Size by Type (2015-2020) 8.4 China Retinal Biologics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Retinal Biologics Market Size (2015-2020) 9.2 Retinal Biologics Key Players in Japan (2019-2020) 9.3 Japan Retinal Biologics Market Size by Type (2015-2020) 9.4 Japan Retinal Biologics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Retinal Biologics Market Size (2015-2020) 10.2 Retinal Biologics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Retinal Biologics Market Size by Type (2015-2020) 10.4 Southeast Asia Retinal Biologics Market Size by Application (2015-2020) 11 India 11.1 India Retinal Biologics Market Size (2015-2020) 11.2 Retinal Biologics Key Players in India (2019-2020) 11.3 India Retinal Biologics Market Size by Type (2015-2020) 11.4 India Retinal Biologics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Retinal Biologics Market Size (2015-2020) 12.2 Retinal Biologics Key Players in Central & South America (2019-2020) 12.3 Central & South America Retinal Biologics Market Size by Type (2015-2020) 12.4 Central & South America Retinal Biologics Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Spark Therapeutics, Inc 13.1.1 Spark Therapeutics, Inc Company Details 13.1.2 Spark Therapeutics, Inc Business Overview and Its Total Revenue 13.1.3 Spark Therapeutics, Inc Retinal Biologics Introduction 13.1.4 Spark Therapeutics, Inc Revenue in Retinal Biologics Business (2015-2020)) 13.1.5 Spark Therapeutics, Inc Recent Development 13.2 F. Hoffmann-La Roche Ltd 13.2.1 F. Hoffmann-La Roche Ltd Company Details 13.2.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue 13.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Introduction 13.2.4 F. Hoffmann-La Roche Ltd Revenue in Retinal Biologics Business (2015-2020) 13.2.5 F. Hoffmann-La Roche Ltd Recent Development 13.3 Regeneron Pharmaceuticals, Inc 13.3.1 Regeneron Pharmaceuticals, Inc Company Details 13.3.2 Regeneron Pharmaceuticals, Inc Business Overview and Its Total Revenue 13.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Introduction 13.3.4 Regeneron Pharmaceuticals, Inc Revenue in Retinal Biologics Business (2015-2020) 13.3.5 Regeneron Pharmaceuticals, Inc Recent Development 13.4 AbbVie Inc 13.4.1 AbbVie Inc Company Details 13.4.2 AbbVie Inc Business Overview and Its Total Revenue 13.4.3 AbbVie Inc Retinal Biologics Introduction 13.4.4 AbbVie Inc Revenue in Retinal Biologics Business (2015-2020) 13.4.5 AbbVie Inc Recent Development 13.5 Johnson & Johnson Services, Inc 13.5.1 Johnson & Johnson Services, Inc Company Details 13.5.2 Johnson & Johnson Services, Inc Business Overview and Its Total Revenue 13.5.3 Johnson & Johnson Services, Inc Retinal Biologics Introduction 13.5.4 Johnson & Johnson Services, Inc Revenue in Retinal Biologics Business (2015-2020) 13.5.5 Johnson & Johnson Services, Inc Recent Development 13.6 Amgen Inc 13.6.1 Amgen Inc Company Details 13.6.2 Amgen Inc Business Overview and Its Total Revenue 13.6.3 Amgen Inc Retinal Biologics Introduction 13.6.4 Amgen Inc Revenue in Retinal Biologics Business (2015-2020) 13.6.5 Amgen Inc Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
